Prime Capital Investment Advisors’s VictoryShares US EQ Income Enhanced Volatility Wtd ETF CDC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,349
Closed -$220K 984
2025
Q1
$220K Sell
3,349
-1,111
-25% -$71.5K ﹤0.01% 941
2024
Q4
$279K Sell
4,460
-331
-7% -$21.5K ﹤0.01% 756
2024
Q3
$311K Sell
4,791
-467
-9% -$28.9K ﹤0.01% 719
2024
Q2
$308K Sell
5,258
-1,918
-27% -$113K ﹤0.01% 716
2024
Q1
$427K Sell
7,176
-730
-9% -$41.3K 0.01% 669
2023
Q4
$447K Sell
7,906
-24,795
-76% -$1.39M 0.01% 598
2023
Q3
$1.83M Buy
32,701
+1,582
+5% +$90K 0.04% 255
2023
Q2
$1.79M Buy
+31,119
New +$1.83M 0.04% 268
2023
Q1
Sell
-40,085
Closed -$2.49M 566
2022
Q4
$2.49M Buy
+40,085
New +$2.51M 0.09% 152

Other funds holding CDC

Prime Capital Investment Advisors's CDC Position: Q2 2025 in Review

Prime Capital Investment Advisors sold out of VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) in Q2 2025, closing a stake of 3,349 shares — an estimated $220K sold.

Prime Capital Investment Advisors first reported a position in CDC in Q4 2022 and held it in 9 quarters. The position peaked at $2.49M in Q4 2022. 97 funds tracked by Wall St. Rank hold CDC as of Q2 2025.

  • Prime Capital Investment Advisors reported no remaining VictoryShares US EQ Income Enhanced Volatility Wtd ETF position as of Q2 2025 after selling out during the quarter.
  • Prime Capital Investment Advisors sold 3,349 VictoryShares US EQ Income Enhanced Volatility Wtd ETF shares in Q2 2025, an estimated $220K.
  • Prime Capital Investment Advisors first reported a position in VictoryShares US EQ Income Enhanced Volatility Wtd ETF in Q4 2022 and held it in 9 quarters.
  • Prime Capital Investment Advisors's VictoryShares US EQ Income Enhanced Volatility Wtd ETF position peaked at $2.49M in Q4 2022.
  • 97 funds tracked by Wall St. Rank held VictoryShares US EQ Income Enhanced Volatility Wtd ETF as of Q2 2025.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2025, filed 23 Jul 2025.